Drs. Karpecki and Schaeffer Discuss the Pharmacological Presbyopia Treatment Consensus Statement

Drs. Paul Karpecki and Jack Schaeffer define presbyopia and discuss the impact of presbyopia on a patient’s everyday life. They discuss the incidence and prevalence of presbyopia in the general population, and the need to diagnose it earlier. They also describe efficacy, safety, and comfort considerations for emerging pharmacological presbyopia treatment options. Drs. Paul Karpecki and Jack Schaeffer discuss emerging pharmacological presbyopia treatments, including ocular surface health considerations, as well as how to best implement these treatments in today’s practice.